Tags

Type your tag names separated by a space and hit enter

Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care.
J Addict Med 2013 Jan-Feb; 7(1):25-32JA

Abstract

OBJECTIVES

There is widespread recognition that services to persons with co-occurring substance use and psychiatric disorders should be accessible, yet most persons with these disorders do not receive care for both problems. Estimates of available services vary widely and have not examined potential variation by level of care.

METHODS

The present study samples 180 community addiction treatment programs and utilizes a standardized observational assessment of these programs using the dual diagnosis capability of addiction treatment (DDCAT) index. By level of care, the sample consisted of 53 outpatient programs, 50 intensive outpatient programs, and 77 residential programs.

RESULTS

Overall, approximately 81.1% of programs across levels of care offered addiction-only services, 18.3% dual diagnosis capable services, and less than 1% dual diagnosis enhanced services. Relative to residential and intensive outpatient programs, outpatient programs were more likely to have greater dual diagnosis capability (dual diagnosis capable services). Outpatient programs scored significantly higher on the DDCAT dimensions associated with program policies and continuity of care. Specific DDCAT benchmark items revealing detailed differences were found in these dimensions and specific assessment and treatment practices. Access to physician-prescriber or to psychotropic medications did not differ by level of care.

CONCLUSIONS

The findings suggest that across levels of care, addiction-treatment systems and programs must continue to improve capacity for patients with co-occurring disorders. The application of a standardized, objective, and observational instrument may be useful to guide and measure the effectiveness of these efforts.

Authors+Show Affiliations

Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, NH 03766, USA.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

23188042

Citation

Lambert-Harris, Chantal, et al. "Organizational Capacity to Address Co-occurring Substance Use and Psychiatric Disorders: Assessing Variation By Level of Care." Journal of Addiction Medicine, vol. 7, no. 1, 2013, pp. 25-32.
Lambert-Harris C, Saunders EC, McGovern MP, et al. Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care. J Addict Med. 2013;7(1):25-32.
Lambert-Harris, C., Saunders, E. C., McGovern, M. P., & Xie, H. (2013). Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care. Journal of Addiction Medicine, 7(1), pp. 25-32. doi:10.1097/ADM.0b013e318276e7a4.
Lambert-Harris C, et al. Organizational Capacity to Address Co-occurring Substance Use and Psychiatric Disorders: Assessing Variation By Level of Care. J Addict Med. 2013;7(1):25-32. PubMed PMID: 23188042.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care. AU - Lambert-Harris,Chantal, AU - Saunders,Elizabeth C, AU - McGovern,Mark P, AU - Xie,Haiyi, PY - 2012/11/29/entrez PY - 2012/11/29/pubmed PY - 2013/5/29/medline SP - 25 EP - 32 JF - Journal of addiction medicine JO - J Addict Med VL - 7 IS - 1 N2 - OBJECTIVES: There is widespread recognition that services to persons with co-occurring substance use and psychiatric disorders should be accessible, yet most persons with these disorders do not receive care for both problems. Estimates of available services vary widely and have not examined potential variation by level of care. METHODS: The present study samples 180 community addiction treatment programs and utilizes a standardized observational assessment of these programs using the dual diagnosis capability of addiction treatment (DDCAT) index. By level of care, the sample consisted of 53 outpatient programs, 50 intensive outpatient programs, and 77 residential programs. RESULTS: Overall, approximately 81.1% of programs across levels of care offered addiction-only services, 18.3% dual diagnosis capable services, and less than 1% dual diagnosis enhanced services. Relative to residential and intensive outpatient programs, outpatient programs were more likely to have greater dual diagnosis capability (dual diagnosis capable services). Outpatient programs scored significantly higher on the DDCAT dimensions associated with program policies and continuity of care. Specific DDCAT benchmark items revealing detailed differences were found in these dimensions and specific assessment and treatment practices. Access to physician-prescriber or to psychotropic medications did not differ by level of care. CONCLUSIONS: The findings suggest that across levels of care, addiction-treatment systems and programs must continue to improve capacity for patients with co-occurring disorders. The application of a standardized, objective, and observational instrument may be useful to guide and measure the effectiveness of these efforts. SN - 1932-0620 UR - https://www.unboundmedicine.com/medline/citation/23188042/Organizational_capacity_to_address_co_occurring_substance_use_and_psychiatric_disorders:_assessing_variation_by_level_of_care_ L2 - http://dx.doi.org/10.1097/ADM.0b013e318276e7a4 DB - PRIME DP - Unbound Medicine ER -